176 related articles for article (PubMed ID: 36298850)
1. Host-Level Susceptibility and IRF1 Expression Influence the Ability of IFN-γ to Inhibit KSHV Infection in B Lymphocytes.
Alomari N; Totonchy J
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298850
[TBL] [Abstract][Full Text] [Related]
2. Cytokine-Targeted Therapeutics for KSHV-Associated Disease.
Alomari N; Totonchy J
Viruses; 2020 Sep; 12(10):. PubMed ID: 32998419
[TBL] [Abstract][Full Text] [Related]
3. Cell Type-Specific Interferon-γ-mediated Antagonism of KSHV Lytic Replication.
Park MK; Cho H; Roh SW; Kim SJ; Myoung J
Sci Rep; 2019 Feb; 9(1):2372. PubMed ID: 30787356
[TBL] [Abstract][Full Text] [Related]
4. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
Katano H
Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
[TBL] [Abstract][Full Text] [Related]
5. Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis.
He M; Cheng F; da Silva SR; Tan B; Sorel O; Gruffaz M; Li T; Gao SJ
Cancer Treat Res; 2019; 177():23-62. PubMed ID: 30523620
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ cytokines in HIV/HHV-8 coinfection.
Silva DMD; Gonçales JP; Silva Júnior JVJ; Lopes TRR; Bezerra LA; Barros de Lorena VM; Duarte Coêlho MRC
J Med Virol; 2021 Jun; 93(6):4033-4037. PubMed ID: 32926412
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3.
Rivera-Soto R; Dissinger NJ; Damania B
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801855
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology.
Li S; Bai L; Dong J; Sun R; Lan K
Adv Exp Med Biol; 2017; 1018():91-127. PubMed ID: 29052134
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
[TBL] [Abstract][Full Text] [Related]
10. Latent infection with Kaposi's sarcoma-associated herpesvirus enhances retrotransposition of long interspersed element-1.
Nakayama R; Ueno Y; Ueda K; Honda T
Oncogene; 2019 May; 38(22):4340-4351. PubMed ID: 30770900
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma-associated herpesvirus immune modulation: an overview.
Rezaee SAR; Cunningham C; Davison AJ; Blackbourn DJ
J Gen Virol; 2006 Jul; 87(Pt 7):1781-1804. PubMed ID: 16760382
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA.
Tagawa T; Gao S; Koparde VN; Gonzalez M; Spouge JL; Serquiña AP; Lurain K; Ramaswami R; Uldrick TS; Yarchoan R; Ziegelbauer JM
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12805-12810. PubMed ID: 30455306
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes.
Host KM; Jacobs SR; West JA; Zhang Z; Costantini LM; Stopford CM; Dittmer DP; Damania B
mBio; 2017 Oct; 8(5):. PubMed ID: 29018115
[TBL] [Abstract][Full Text] [Related]
14. Lymphoid disorders associated with HHV-8/KSHV infection: facts and contentions.
Gaidano G; Castaños-Velez E; Biberfeld P
Med Oncol; 1999 Apr; 16(1):8-12. PubMed ID: 10382936
[TBL] [Abstract][Full Text] [Related]
15. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
16. Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Polizzotto MN; Uldrick TS; Wang V; Aleman K; Wyvill KM; Marshall V; Pittaluga S; O'Mahony D; Whitby D; Tosato G; Steinberg SM; Little RF; Yarchoan R
Blood; 2013 Dec; 122(26):4189-98. PubMed ID: 24174627
[TBL] [Abstract][Full Text] [Related]
17. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y
Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388
[TBL] [Abstract][Full Text] [Related]
18. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
[TBL] [Abstract][Full Text] [Related]
19. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
[TBL] [Abstract][Full Text] [Related]
20. Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS).
Polizzotto MN; Uldrick TS; Wyvill KM; Aleman K; Marshall V; Wang V; Whitby D; Pittaluga S; Jaffe ES; Millo C; Tosato G; Little RF; Steinberg SM; Sereti I; Yarchoan R
Clin Infect Dis; 2016 Mar; 62(6):730-738. PubMed ID: 26658701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
